Finasteride Pregnancy & Lactation Safety: What Patients and Partners Must Know
Taking finasteride during pregnancy, handling a damaged tablet and having a partner who takes finasteride are different exposure situations. Finasteride should not be taken during pregnancy. A male partner's use does not expose the pregnancy to the same dose as the pregnant person taking a tablet. [1,2]
Finasteride reduces conversion of testosterone to dihydrotestosterone, or DHT. Its effects on DHT explain both its use for hair loss or prostate enlargement and its relevance to male fetal development. [1] Family-planning decisions are clearest when fetal exposure and sperm production are discussed separately.
Pregnancy: what the label actually says
The Propecia prescribing information contraindicates use in women who are or may become pregnant because suppression of DHT can affect male external genital development. [1]
Older material often calls finasteride "Category X." FDA removed the A, B, C, D and X pregnancy categories under its pregnancy and lactation labeling rule. The practical point is the drug-specific pregnancy information, rather than using the old letter as a current classification system. [3]
Correctly interpreting the animal findings
The Propecia label reports no male fetal abnormalities in rhesus monkeys given intravenous finasteride up to 800 ng/day, corresponding to about 930 times the highest estimated maternal blood exposure from semen of men taking 1 mg/day. A much higher oral dose, 2 mg/kg/day, produced male external genital abnormalities. [1]
The low-exposure and high-exposure experiments should not be reversed or described as the same experiment. They explain why direct maternal dosing and exposure through semen are assessed differently.
A partner taking finasteride: semen exposure
The NHS describes harm from the small amount of finasteride in semen as very unlikely. It notes that manufacturers recommend condoms, while most experts consider them unnecessary for this purpose. [4] MotherToBaby's June 2026 fact sheet likewise states that exposure through semen is not expected to reach an amount that causes fetal problems. [2]
A recent source deserves accurate context: a 2025 analysis of the FDA adverse-event reporting database identified a reporting signal involving paternal finasteride exposure and cryptorchidism, or undescended testes. That analysis compared patterns in submitted reports; it did not follow a representative group of exposed and unexposed pregnancies. It therefore cannot supply a birth-defect rate or establish that finasteride caused the reported outcomes. [5]
The decision for a couple should start with the actual situation: direct maternal use, incidental contact, paternal use alone, or a separate fertility concern. These should not all be assigned a blanket medication-stop schedule.
Handling tablets during pregnancy
The coating on an intact tablet limits contact with the active drug during ordinary handling. Pregnant people should avoid crushed or broken tablets. If contact occurs, wash the exposed area and contact the prescriber with the product, timing and type of contact. MotherToBaby describes it as unlikely that incidental skin contact would absorb enough to increase pregnancy risk. [2]
An intact tablet briefly touched while filling a pill organizer is a different event from swallowing a tablet. When asking about an exposure, describe what happened rather than only saying "I was exposed to finasteride."
Does finasteride affect male fertility?
The studies answer different questions depending on the dose and the men enrolled.
| Study | Who was studied | Main semen findings |
|---|---|---|
| Overstreet and colleagues, 1999 | 181 healthy men randomized to 1 mg/day or placebo; 79 provided serial semen samples | No significant effect on sperm concentration, total sperm per ejaculate, motility or morphology over 48 weeks [6] |
| Amory and colleagues, 2007 | 99 healthy men randomized to finasteride 5 mg, dutasteride or placebo for one year | Finasteride was associated with changes in several semen measures; total sperm count was significantly lower than baseline at 26 weeks but not at 52 weeks or 24-week follow-up [7] |
| Samplaski and colleagues, 2013 | 27 finasteride users assessed in an infertility clinic, average dose 1.04 mg/day | Sperm counts increased after stopping, with an average 11.6-fold increase; this was a selected fertility-clinic group [8] |
The 1 mg randomized study is reassuring about average semen measures in healthy men. The infertility-clinic study identifies a different practical situation: a man with a low sperm count may improve after discontinuation even at a hair-loss dose. The clinic result is not a prediction that every user's count will increase elevenfold.
Sexual function is another part of conception planning. Reduced libido or erection difficulties can affect attempts to conceive independently of the semen count. The NHS recommends discussing bothersome sexual effects with the prescriber. [4]
Is a one-month or three-month washout required?
A blood-donation waiting period is not a conception rule. The American Red Cross lists a one-month wait after the last finasteride dose for blood donation. That policy concerns the recipient of donated blood; it does not establish that every man must stop finasteride for a month before trying to father a child. [9]
Drug clearance and sperm recovery also run on different clocks. MotherToBaby estimates that most finasteride is cleared within about two days on average in healthy, nonpregnant adults. [2] That pharmacokinetic estimate does not predict when an individual's sperm count will change.
If a semen analysis is abnormal, the prescriber or fertility specialist can consider a medication pause and plan repeat testing. The relevant outcome is the semen response and the couple's fertility evaluation, rather than simply reaching an arbitrary number of medication-free days. The infertility-clinic study supports reviewing finasteride in men with low counts; it does not establish a universal three-month fetal-protection interval. [8]
For a man without a fertility problem, paternal use alone and an abnormal semen analysis should not be treated as the same reason to interrupt therapy.
Breastfeeding and maternal finasteride use
Finasteride use during breastfeeding has not been studied, and its transfer into human milk is unknown. MotherToBaby advises against maternal use while breastfeeding and recommends discussing other treatment options. [2]
This is a question about the nursing parent's medication. It should not be presented as evidence that a father taking finasteride exposes an infant through breast milk.
For someone who becomes pregnant while taking finasteride, stop taking it and contact the prescribing clinician promptly. Bring the strength, route, dates taken and estimated pregnancy timing. An exposure assessment should use those details rather than attempting to calculate a human outcome from an animal dose.
Make the treatment discussion specific
A useful appointment begins with four facts:
- Who takes the medicine? Maternal use and paternal use lead to different questions.
- Which product and dose? Identify the actual tablet or topical preparation, including combined products.
- What is the concern? Separate an accidental exposure, a pregnancy already underway, difficulty conceiving and a documented low sperm count.
- Why was it prescribed? Hair-loss treatment and management of prostate enlargement have different alternatives and consequences of interruption.
If a pause is chosen, agree on what it is intended to accomplish and when to reassess. A hair-loss plan should address what happens during the pause; a prostate-treatment plan should address urinary symptoms. Simply substituting another medicine without reviewing its own effects does not answer the fertility question.
Common questions
Does paternal finasteride use mean pregnancy should be avoided?
Paternal use is not equivalent to direct maternal dosing. NHS guidance describes fetal harm from semen exposure as very unlikely. A personal fertility problem warrants its own assessment. [4]
Can someone use topical finasteride during pregnancy instead?
MotherToBaby recommends avoiding finasteride in any form during pregnancy. Changing the route does not make it a pregnancy treatment option. [2]
Is dutasteride covered by the same stopping schedule?
No. The semen trial studied finasteride and dutasteride as separate treatment groups. [7] Do not copy a finasteride clearance estimate or blood-donation interval onto a different drug.
Does the infertility study prove finasteride makes most men infertile?
No. It enrolled men already presenting for a fertility evaluation. Its findings support looking for a reversible contributor in that setting, not estimating infertility frequency among all users. [8]
References
- Organon. Propecia prescribing information, revised August 2022.
- MotherToBaby. Finasteride fact sheet, updated June 2026.
- FDA. Pregnancy and lactation labeling resources.
- NHS. Fertility and pregnancy while taking finasteride.
- Zeng and colleagues. Paternal drug exposure in the FDA adverse-event reporting system, 2025.
- Overstreet and colleagues. Finasteride 1 mg and spermatogenesis in healthy young men, 1999.
- Amory and colleagues. Finasteride 5 mg and dutasteride effects on semen parameters, 2007.
- Samplaski and colleagues. Finasteride discontinuation in a male infertility clinic, 2013.
- American Red Cross. Blood-donor eligibility criteria and medication waiting periods.